Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer

被引:29
|
作者
Man, A
Pickles, T
Chi, KN
机构
[1] British Columbia Canc Agcy, Dept Radiat, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada
来源
JOURNAL OF UROLOGY | 2003年 / 170卷 / 03期
关键词
prostate; prostatic neoplasms; radiotherapy; risk; mongoloid race;
D O I
10.1097/01.ju.0000081423.37043.b4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We compared survival outcomes in patients of Asian descent treated with curative intent radiation therapy for prostate cancer with that in the nonAsian population in British Columbia, Canada. Materials and Methods: Since 1994, 1,872 men treated with curative intent radiotherapy for prostate cancer have been followed prospectively at our-provincial institution, where cancer care delivery is coordinated for the province of British Columbia. Patients are treated uniformly based on provincial policies and guidelines. Patients were divided into 63 Asian (3.6%) and 1,804 nonAsian (96.4%) patients by surname with Asian names checked by telephone contact. Three risk groups were defined based on pretreatment prostate specific antigen, biopsy Gleason score and clinical T staging. For the whole cohort and each risk group survival was estimated using the Kaplan-Meier method and comparisons were made between the Asian and nonAsian populations. Results: The mean age of Asian and nonAsian men was 71.5 and 71 years, respectively. Median prostate specific antigen was 11.4 and 10 ng/ml, respectively (p = 0.7). Median Gleason score was 7 for Asian patients and 6 for nonAsian patients. (p = 0.002). There were twice the percentage of Asian patients with Gleason scores 8 or greater than nonAsians (26.5% vs 13.8%, p = 0.003). More Asian patients had stage 3 or 4 disease than nonAsians (44.8% vs 34.9%, p = 0.095). A greater proportion of Asian patients were classified as being at high risk than the nonAsian population (60.3% vs 47.6%, p = 0.04). For the entire cohort, and the low, intermediate and high risk groups there were no differences in time to first failure, or cause specific or overall survival for Asian vs nonAsian men. Conclusions: A greater proportion of patients of Asian descent present with high risk prostate cancer than nonAsian patients, which could be due to intrinsic biological differences and/or differences in diagnostic patterns. Survival outcomes after radiotherapy are the same for the 2 populations.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 50 条
  • [21] Oncological outcomes after radical prostatectomy and radiotherapy for high risk prostate cancer
    Chiu, P. K. F.
    Tong, S. Y. T.
    Poon, D. M.
    Chan, E. S. Y.
    Hou, S. M.
    Ng, C. F.
    BJU INTERNATIONAL, 2015, 115 : 7 - 7
  • [22] Clinical-Prostate cancer The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer
    Tilki, Derya
    Mandel, Philipp
    Karakiewicz, Pierre I.
    Heinze, Alexander
    Huland, Hartwig
    Graefen, Markus
    Knipper, Sophie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) : 379 - 385
  • [23] RADIOTHERAPY AFTER RADICAL PROSTATECTOMY IN PROSTATE CANCER
    Lainez, C.
    Vila, A.
    Sanchez-Reyes, A.
    Artola, N.
    Moya, L. M.
    Julia, J. C.
    Pedro, A.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S338 - S339
  • [24] Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer - The prostate cancer outcomes study
    Stanford, JL
    Feng, ZD
    Hamilton, AS
    Gilliland, FD
    Stephenson, RA
    Eley, JW
    Albertsen, PC
    Harlan, LC
    Potosky, AL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03): : 354 - 360
  • [25] Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis
    Abdollah, Firas
    Schmitges, Jan
    Sun, Maxine
    Jeldres, Claudio
    Tian, Zhe
    Briganti, Alberto
    Shariat, Shahrokh F.
    Perrotte, Paul
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (09) : 836 - 844
  • [26] 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
    Hamdy, F. C.
    Donovan, J. L.
    Lane, J. A.
    Mason, M.
    Metcalfe, C.
    Holding, P.
    Davis, M.
    Peters, T. J.
    Turner, E. L.
    Martin, R. M.
    Oxley, J.
    Robinson, M.
    Staffurth, J.
    Walsh, E.
    Bollina, P.
    Catto, J.
    Doble, A.
    Doherty, A.
    Gillatt, D.
    Kockelbergh, R.
    Kynaston, H.
    Paul, A.
    Powell, P.
    Prescott, S.
    Rosario, D. J.
    Rowe, E.
    Neal, D. E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (15): : 1415 - 1424
  • [27] Pelvic cancer incidence after radiotherapy for localized prostate cancer
    Moon, K
    Stukenborg, GJ
    Keim, J
    Theodorescu, D
    JOURNAL OF UROLOGY, 2006, 175 (04): : 70 - 70
  • [28] SECONDARY BLADDER CANCER AFTER RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER
    Abern, Michael
    Dude, Ann
    Coogan, Christopher
    JOURNAL OF UROLOGY, 2011, 185 (04): : E190 - E190
  • [29] Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
    Zedan, Ahmed H.
    Hansen, Torben F.
    Assenholt, Jannie
    Madsen, Jonna S.
    Osther, Palle J. S.
    PROSTATE, 2019, 79 (04): : 425 - 432
  • [30] RE: Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer Response
    Hoffman, Richard M.
    Penson, David F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (03):